Medical Device Coordination Group Document MDCG 2022-10
Clinical Trials Expert Group Document
Page 4 of 12
Device for performance study according to IVDR Article 2 (45) means a device intended by
the manufacturer to be used in a performance study. A device intended to be used for
research purposes, without any medical objective, shall not be deemed to be a device for
performance study
Stratification: Within clinical trials, a method used in the randomization to ensure equal
distribution of chosen variables between treatment arms
In-house IVD: An IVD manufactured and used within the same health institution as outlined
in IVDR Article 5 (5). Health institution is defined in IVDR Article 2 (29).
Instructions for use according to Article 2 (14) IVDR means the information provided by the
manufacturer to inform the user of the device's intended purpose and proper use and of any
precautions to be taken
Intended purpose according to Article 2 (12) IVDR means the use for which a device is
intended according to the data supplied by the manufacturer on the label, in the instructions
for use or in promotional or sales materials or statements or as specified by the manufacturer
in the performance evaluation
Interventional clinical performance study according to Article 2 (46) IVDR means a clinical
performance study where the test results may influence patient management decisions
and/or may be used to guide treatment
Clinical Trial according to Article 2 (2) CTR, means a clinical study which fulfils any of the
following conditions: (a) the assignment of the subject to a particular therapeutic strategy is
decided in advance and does not fall within normal clinical practice of the Member State
concerned; (b) the decision to prescribe the investigational medicinal products is taken
together with the decision to include the subject in the clinical study; or (c) diagnostic or
monitoring procedures in addition to normal clinical practice are applied to the subjects. By
definition, all clinical trials are “interventional” For clarification on the differentiation between
clinical trial and non-interventional study, reference is also made to Question 1.5 in the Q&A
published on EudraLex vol. 10.
In vitro diagnostic medical device (IVD) is a medical device as defined in point (1) of
Article 2 of Regulation (EU) 2017/745 on medical devices and, more specifically, according
to Article 2 (2) IVDR, any medical device which is a reagent, reagent product, calibrator,
control material, kit, instrument, apparatus, piece of equipment, software or system, whether
used alone or in combination, intended by the manufacturer to be used in vitro for the
examination of specimens, including blood and tissue donations, derived from the human
body, solely or principally for the purpose of providing information on one or more of the
following: (a) concerning a physiological or pathological process or state; (b) concerning
congenital physical or mental impairments; (c) concerning the predisposition to a medical
condition or a disease; (d) to determine the safety and compatibility with potential recipients;
(e) to predict treatment response or reactions; (f) to define or monitoring therapeutic
measures. Specimen receptacles shall also be deemed to be in vitro diagnostic medical
devices;